Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2020;71(2021):209–49.

Google Scholar 

Cooke SL, Brenton JD. Evolution of platinum resistance in high-grade serous ovarian cancer. Lancet Oncol. 2011;12:1169–74.

Article  CAS  PubMed  Google Scholar 

Yuan Y. Il-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures. Int J Oncol. 2011;40:1171–9.

PubMed  PubMed Central  Google Scholar 

Gyamfi J, Lee Y, Eom M, Choi J. Interleukin-6/stat3 signalling regulates adipocyte induced epithelial-mesenchymal transition in breast cancer cells. Sci Rep. 2018;8:8859.

Article  PubMed  PubMed Central  Google Scholar 

Zhang T, Yang J, Sun Y, Song J. Interleukin-6 and hypoxia synergistically promote EMT-mediated invasion in epithelial ovarian cancer via the IL-6/STAT3/HIF-1α feedback loop. Anal Cell Pathol. 2023;2023:1–14.

Article  CAS  Google Scholar 

Xu S, Yu C, Ma X, et al. IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells. Eur J Pharmacol. 2021;894: 173817.

Article  CAS  PubMed  Google Scholar 

Pan G, Liu Y, Shang L, Zhou F, Yang S. EMT-associated microRNAs and their roles in cancer stemness and drug resistance. Cancer Commun. 2021;41(3):199–217.

Article  Google Scholar 

Macciò A, Madeddu C. The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications-a review. J Mol Med. 2013;91:1355–68.

Article  PubMed  Google Scholar 

Bose S, Saha P, Chatterjee B, Srivastava AK. Chemokines driven ovarian cancer progression, metastasis and chemoresistance: potential pharmacological targets for cancer therapy. Semin Cancer Biol. 2022;86(Pt 2):568–79.

Article  CAS  PubMed  Google Scholar 

Mir MA, Bashir M, Jan N. The role of interleukin (IL)-6/IL-6 receptor axis in cancer, cytokine and chemokine networks in cancer. Singapore: Springer; 2023. p. 137–64.

Google Scholar 

Colomiere M, Ward AC, Riley C, Trenerry MK, Cameron-Smith D, Findlay J, et al. Cross talk of signals between EGFR and IL-6 through jak2/stat3 mediate epithelial–mesenchymal transition in ovarian carcinomas. Br J Cancer. 2009;100:134–44.

Article  CAS  PubMed  Google Scholar 

Cheng Z, Sun B, Wang S, Gao Y, Zhang Y, Zhou H, et al. Nuclear factor-κb–dependent epithelial to mesenchymal transition induced by HIF-1α activation in pancreatic cancer cells under hypoxic conditions. PLoS ONE. 2011;6: e23752.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng Z, Wang D, Liu T, Liu W, Xia W, Xu J, et al. Effects of the hif-1α and NF-κb loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells. Oncol Rep. 2014;31:1891–8.

Article  CAS  PubMed  Google Scholar 

Joseph JV, Conroy S, Pavlov K, Sontakke P, Tomar T, Eggens-Meijer E, et al. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis. Cancer Lett. 2015;359:107–16.

Article  CAS  PubMed  Google Scholar 

Yang M, Wu K. Twist activation by hypoxia inducible factor-1 (hif-1): implications in metastasis and development. Cell Cycle. 2008;7:2090–6.

Article  CAS  PubMed  Google Scholar 

Zare M, Bastami M, Solali S, Alivand MR. Aberrant mirna promoter methylation and emt-involving mirnas in breast cancer metastasis: diagnosis and therapeutic implications. J Cell Physiol. 2018;233:3729–44.

Article  CAS  PubMed  Google Scholar 

Mahmood N, Mushtaq S, Jamal Q, Hanif M, Akhlaq H, Awan R. Potential utility of cell free high mobility group at-hook 2 (hmga2) as a prognostic biomarker in liquid biopsies of oral squamous cell carcinoma. Asian Pacific J Cancer Prev: APJCP. 2021;22:407.

Article  CAS  Google Scholar 

Guo L, Chen C, Shi M, Wang F, Chen X, Diao D, et al. Stat3-coordinated lin-28–let-7–hmga2 and mir-200–zeb1 circuits initiate and maintain oncostatin m-driven epithelial–mesenchymal transition. Oncogene. 2013;32:5272–82.

Article  CAS  PubMed  Google Scholar 

Mahajan A, Liu Z, Gellert L, Zou X, Yang G, Lee P, et al. Hmga2: a biomarker significantly overexpressed in high-grade ovarian serous carcinoma. Mod Pathol. 2010;23:673–81.

Article  CAS  PubMed  Google Scholar 

Shi Z, Li X, Wu D, Tang R, Chen R, Xue S, et al. Silencing of hmga2 suppresses cellular proliferation, migration, invasion, and epithelial–mesenchymal transition in bladder cancer. Tumor Biology. 2016;37:7515–23.

Article  CAS  PubMed  Google Scholar 

Xi Y, Xin X, Ye H. Effects of hmga2 on malignant degree, invasion, metastasis, proliferation and cellular morphology of ovarian cancer cells. Asian Pacific J Trop Med. 2014;7:289–92.

Article  CAS  Google Scholar 

Sulaiman SA, Ab Mutalib N, Jamal R. Mir-200c regulation of metastases in ovarian cancer: potential role in epithelial and mesenchymal transition. Front Pharmacol. 2016;7:271.

Article  PubMed  PubMed Central  Google Scholar 

Abaurrea A, Araujo AM, Caffarel MM. The role of the IL-6 cytokine family in epithelial-mesenchymal plasticity in cancer progression. Int J Mol Sci. 2021;22(15):8334.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang CX, Chen N, Wu XJ, He Y, Huang CH, Liu H, Wang WM, Wang HL. Zebrafish let-7b acts downstream of hypoxia-inducible factor-1α to assist in hypoxia-mediated cell proliferation and cell cycle regulation. Life Sci. 2017;171:21–9.

Article  CAS  PubMed  Google Scholar 

Shang Y, Chen H, Ye J, Wei X, Liu S, Wang R. Hif-1α/ascl2/mir-200b regulatory feedback circuit modulated the epithelial-mesenchymal transition (EMT) in colorectal cancer cells. Exp Cell Res. 2017;360:243–56.

Article  CAS  PubMed  Google Scholar 

Yang W, Ma J, Zhou W, Cao B, Zhou X, Zhang H, Zhao Q, Liu H, Fan D. Reciprocal regulations between miRNAs and HIF-1α in human cancers. Cell Mol Life Sci. 2019;76(3):453–71.

Article  CAS  PubMed  Google Scholar 

Shan F, Li J, Huang QY. HIF-1 alpha-induced up-regulation of miR-9 contributes to phenotypic modulation in pulmonary artery smooth muscle cells during hypoxia. J Cell Physiol. 2014;229(10):1511–20.

Article  CAS  PubMed  Google Scholar 

Kang L, Cui X, Zhang Y, Yang C, Jiang Y. Identification of microRNAs associated with sexual maturity in chicken ovary by illumina small RNA deep sequencing. BMC Genomics. 2013;14:352.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao Y, Wu J. Microrna-200c and microrna-141 as potential diagnostic and prognostic biomarkers for ovarian cancer. Tumor Biology. 2015;36:4843–50.

Article  CAS  PubMed  Google Scholar 

Tsai C, Lin L, Wang C, Chiu Y, Chou Y, Chiu S, et al. Over-expression of cofilin-1 suppressed growth and invasion of cancer cells is associated with up-regulation of let-7 microRNA. Biochim Biophys Acta Mol Basis Dis. 1852;2015:851–61.

Google Scholar 

Yan Y, Zhang F, Fan Q, Li X, Zhou K. Breast cancer-specific trail expression mediated by miRNA response elements of let-7 and mir-122. Neoplasma. 2014;61:672–9.

Article  CAS  PubMed  Google Scholar 

Canale M, Foschi FG, Andreone P, Ercolani G, Marisi G, Conti F, et al. Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery. HPB. 2022;24:244–54.

Article  PubMed  Google Scholar 

Mayr C, Hemann MT, Bartel DP. Disrupting the pairing betweenlet-7 and hmga2 enhances oncogenic transformation. Science. 2007;315:1576–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rokavec M, Wu W, Luo J. IL6-mediated suppression of mir-200c directs constitutive activation of inflammatory signaling circuit driving transformation and tumorigenesis. Mol Cell. 2012;45:777–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garg M, Potter JA, Abrahams VM. Identification of microRNAs that regulate tlr2-mediated trophoblast apoptosis and inhibition of IL-6 miRNA. PLoS ONE. 2013;8: e77249.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim HL, Cassone M, Otvos L, Vogiatzi P. HIF-1α and STAT3 client proteins interacting with the cancer chaperone Hsp90: therapeutic considerations. Cancer Biol Ther. 2008;7(1):10–4.

Article  CAS  PubMed  Google Scholar 

Nilsson CL, Dillon R, Devakumar A, Shi SDH, Greig M, Rogers JC, et al. Quantitative phosphoproteomic analysis of the stat3/il-6/hif1α signaling network: an initial study in gsc11 glioblastoma stem cells. J Proteome Res. 2010;9:430–43.

Article  CAS  PubMed  Google Scholar 

Kozak J, Jonak K, Maci